Login to Your Account

Discovery Labs to Meet with FDA to Propose Limited Surfaxin Trial

By Catherine Hollingsworth

Monday, September 14, 2009
Discovery Laboratories Inc. has not given up on its Surfaxin drug candidate for respiratory distress syndrome, signaling Friday that it would propose a limited clinical trial to gain FDA approval. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription